Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00126308
Recruitment Status : Terminated (no change in primary endpoint at week 48)
First Posted : August 3, 2005
Last Update Posted : April 2, 2009
The University of New South Wales
Bristol-Myers Squibb
Gilead Sciences
Merck Sharp & Dohme Corp.
Hoffmann-La Roche
AIDS Council of New South Wales
Information provided by:
Kirby Institute

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : May 2007
  Actual Study Completion Date : May 2007